Awadh Al Ketbi talks with DHA's Innovation Centre officials on Saturday. WAM
The Dubai Health Authority (DHA) recently announced its plans to enhance the use of smart health technologies on the occasion of the UAE Innovation Month 2021.
DHA has collaborated with Enpy, a Dubai firm; to explore the use of AI-powered device for remote-patient monitoring. Enpy is a start-up UAE company, based in Dubai, specialising in Medical Artificial Intelligence. It has designed the non-invasive innovative medical device.
DHA is also expanding and adding newer specialisations to its Doctor for Every Citizen telemedicine service.
Awadh Al Ketbi during the inspectional visit to the DHA's Innovation Centre. WAM
During his inspectional visit of the DHA’s Innovation Centre, Awadh Al Ketbi, Director General of the Dubai Health Authority emphasised the importance of fostering and promoting a culture of innovation, particularly in the health sector.
He added that the DHA will continue to focus on research, innovation and implementation of smart technologies across all aspects of healthcare delivery and management. At the same time, the authority will continue its focus on medical education and specialisations in the health sector.
DHA plans to implement such technologies across its primary healthcare centres to foster its remote patient monitoring initiatives to empower patients, ensure they stay on-track with their health and to aid in early detection. It will also help healthcare professionals by providing them with vital patient data to ensure regular follow-up and better patient compliance.
A smart device is on display.
Dr Manal Taryam, CEO of Primary Healthcare Sector at the DHA said, "We are keen to use the latest health technologies with an aim to better both healthcare management and patient-centered care. Over the last few years, we have focused on home patient monitoring especially for elderly patients. We have also swiftly foraged into telemedicine.The use of technology for remote-patient monitoring is of particular importance in the current healthcare landscape of the world and we are keen to continue collaborating with firms locally and globally to implement healthcare technologies after an evidence-based analysis."
Epsy’s innovative all-in-one non-invasive medical device is paired with a smartphone/tablet application, it is powered by Artificial Intelligence and measures vital signs. It is an all-in-one advanced AI-powered healthcare companion at home, combining integrated medical sensors, embedded electronics, and a unique user-interface to guide users regularly in making the best decisions for their health.
UAE-based tech company Loyica has continued to provide digital transformation services to local businesses using Saphyte, a cloud-based sales platform designed by the company to enhance partner businesses’ marketing efforts, allowing them to continue reaching out to customers and adapt to new trends in the supply chain.
Data and artificial intelligence (AI) are expected to become key pillars that will build and grow the UAE’s digital economy in the future, adding a major boost to the country’s gross domestic product (GDP)
Salim Bin Lahej thanked all the strategic partners who supported the Health Fund Office’s humanitarian initiatives including the Islamic Affairs and Charitable Activities Department in Dubai, Awqaf and Minors Affairs Foundation and other charities and philanthropists.
The ten articles cover the UAE’s legacy, digital reputation, respect for others, positive investment, good manners, digital privacy, publishing credibility, responsibility and systems, digital ethics and balanced usage.
The helmet sends an intermittent oscillating magnetic field resulting from the rotation of a magnet which must be used at first for two hours under the supervision of a specialist.
It also showed a map of the path of "Zhurong," from north to south, starting from its landing on the surface of Mars until July 21.
The unique feature of this drug is that it has no side effects and its effectiveness depends on the estrogen receptors in the majority of breast tumors.